Rapport Therapeutics (RAPP) Change in Acquisitions & Divestments (2024 - 2026)
Rapport Therapeutics (RAPP) has 3 years of Change in Acquisitions & Divestments data on record, last reported at $10.1 million in Q1 2026.
- On a quarterly basis, Change in Acquisitions & Divestments changed N/A to $10.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $178.0 million, a 13.53% decrease, with the full-year FY2025 number at $167.9 million, down 19.96% from a year prior.
- Change in Acquisitions & Divestments reached $10.1 million in Q1 2026 per RAPP's latest filing, down from $22.9 million in the prior quarter.
- Over the last five years, Change in Acquisitions & Divestments for RAPP hit a ceiling of $116.7 million in Q4 2024 and a floor of $3.9 million in Q1 2024.
- A 3-year average of $48.5 million and a median of $38.6 million in 2024 define the central range for Change in Acquisitions & Divestments.
- On a YoY basis, Change in Acquisitions & Divestments climbed as much as 209.77% in 2025 and fell as far as 80.37% in 2025.
- Tracing RAPP's Change in Acquisitions & Divestments over 3 years: stood at $116.7 million in 2024, then plummeted by 80.37% to $22.9 million in 2025, then plummeted by 56.04% to $10.1 million in 2026.
- Business Quant data shows Change in Acquisitions & Divestments for RAPP at $10.1 million in Q1 2026, $22.9 million in Q4 2025, and $45.0 million in Q3 2025.